Immatics stock holds steady as Q2 loss contrasts with strong cash position

Published on 09/21/2026 at 15:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Immatics stock closed at USD 7.70 on Nasdaq on September 19, 2026, leaving the shares 14.0 percent below their 52-week high. In Q2 2026, the biotech posted USD 7.3 million in revenue against a net loss of USD 47.2 million but ended June with USD 772.4 million in cash.

IMTX, NL0015255052, Illustration mit AI erstellt.

Immatics stock (ISIN NL0015255052) traded at USD 7.70 on Nasdaq as of September 19, 2026, leaving the biotech’s shares below their recent 52-week peak but supported by a sizable cash buffer after the latest quarterly results.

Q2 2026 figures show loss alongside robust liquidity

According to ad-hoc-news.de, Immatics N.V. reported second-quarter 2026 revenue of USD 7.3 million, while posting a net loss of USD 47.2 million for the same period.

As the same overview notes, cash and cash equivalents stood at USD 772.4 million as of June 30, 2026, giving the company a substantial liquidity cushion relative to its Q2 loss and supporting its ability to fund ongoing clinical development and partnerships.ad-hoc-news.de

Analyst targets sit far above the current share price

In addition to the reported figures, Immatics stock is also shaped by analyst expectations. According to ad-hoc-news.de, data from MarketBeat put the average analyst price target for Immatics stock at USD 15.50, based on coverage by 12 analysts and including 4 Buy ratings in the current consensus snapshot.

That USD 15.50 consensus target compares with the USD 7.70 closing price on September 19, 2026, implying an upside gap of about 101.3 percent between where the stock currently trades and the average expectation of covering analysts.ad-hoc-news.de

Stock remains mid-range in its 52-week corridor

From a market perspective, the same price snapshot shows Immatics stock trading within its established 52-week corridor but still clearly below its recent high. Immatics shares closed at USD 7.70 on September 19, 2026, versus a 52-week high of USD 8.95 and a 52-week low of USD 3.60.ad-hoc-news.de

At USD 7.70, the stock sat 14.0 percent below the 52-week high of USD 8.95 and 113.9 percent above the 52-week low of USD 3.60, indicating that the shares have roughly doubled from their low but have not yet revisited the top of the range.ad-hoc-news.de

Closing price and market snapshot

Per the recent market data cited by ad-hoc-news.de, Immatics stock closed at USD 7.70 on Nasdaq on September 19, 2026, with a market capitalization of USD 848.0 million at that same date.